Amputation

Between Groundhog Day’s prediction for 6 more weeks of winter and the recent cold fronts rushing into both northern and southern states, wintery weather may linger this year – and with it, the chance for frostbite could stick around, too.

Use of SGLT2 inhibitors was associated with improved kidney health among a diverse multiethnic cohort of Asian adults with type 2 diabetes, researchers found in a retrospective cohort study.

Endovascular therapy with stent implantation confers similar outcomes and lower complication rates vs. vascular bypass surgery for symptomatic femoropopliteal peripheral artery disease, regardless of sex, a speaker reported.

Abbott announced the FDA has approved its novel below-the-knee, bioresorbable, drug-eluting scaffold for people with chronic limb-threatening ischemia.

SAN FRANCISCO — Results showed use of local antibiotic-loaded hydroxyapatite and calcium sulfate biocomposite void filler may increase limb salvage and ulcer healing rates among patients with diabetic foot infections and vascular disease.

Adults with kidney failure at risk for diabetes-related foot ulcers who receive foot and ankle care may have a lower chance of diabetes-related amputation and death, according to recently published data.

Aurlumyn injection has been approved for the treatment of severe frostbite in adults to reduce the risk of finger or toe amputation, the FDA announced in a press release.

Prostheses and osseointegration may unlock innovative surgical approaches for patients undergoing upper extremity amputation, according to a presenter at the Bionic Reconstruction Conference.

An everolimus-eluting bioresorbable scaffold did not affect wound healing compared with angioplasty in patients with chronic limb-threatening ischemia, according to new data from the LIFE-BTK trial.

Most patients with severe chronic limb-threatening ischemia treated with a transcatheter deep venous arterialization system achieved limb salvage at 12 months, according to new data from the PROMISE II trial.